To identify the novel receptor tyrosine kinases (RTKs) critical to the proliferation of hematopoietic stem cells, we performed polymerase chain reaction-based cloning from highly purified murine hematopoietic stem cells. Lineage marker-negative, c-KIT-positive, and Ly6AIE-or Sca-l -positive (Lin-c-KITSca-l') cells were sorted by a fluorescenceactivated cell sorter. Two sets of degenerate oligonucleotide primers were directed to the conserved sequences of the catalytic domain, and were used t o amplify cDNAs that encode protein tyrosine kinases (PTKs). One hundred cDNA clones were sequenced and 8 RTKs were identified, as well as 12 non-RTKs and 2 serinelthreonine kinases. Sixteen cDNAs were identical to the known kinase genes (PKCp, ABL, c-KIT, FLK-l, FLK-2, IGFlR, and ECK). Six novel cDNA sequences (stk series) were identified. However, three of them turned out t o be BPK, RYK, and 7EK. The remaining three showed high homology t o S6 kinase II. JAK-2, and v-
S€A/c-M€T, respectively. Characterization of full-length cDNA sequence of the v-SEAlcMET-related gene showed that this was a novel RTK gene and we named this gene STK (stem cell-derived tyrosine kinase). We identified two distinct forms of STK cDNA; the short one encoded a putative truncated protein that lacked most of the extracellular domain. STKwas expressed at various stages of hematopoietic cells, including stem cells, but we could not detect any apparent expression in other adult tissues. The expression of the truncated form of mRNA was more predominant than that of the complete form. STK was assigned by fluorescent in situ hybridization to the R-positive F1 band of chromosome 9, the same region t o which hepatic growth factorlike protein has been assigned. Characterization of these PTKs, including STK, w i l l be helpful t o elucidate the molecular mechanism of the growth regulation of hematopoietic stem cells. 0 1994 b y The American Society of Hematology.
stem cell function completely in W and S1 mutant ~n i c e .~, '~ Other systems that are involved in the early stage of hematopoiesis or that are compensative for the SLFIc-KIT system remain to be identified.
To identify the RTKs involved in the early stage of hematopoiesis, we prepared RNA from highly purified murine hematopoietic stem cells for polymerase chain reaction (PCR)-based cloning of RTK-related cDNA sequences. Sequencing of the cDNAs identified eight RTK-related genes. 
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c-KIT monoclonal antibody (MoAb; ACK-2), fluorescein isothiocyanate (FITC)-conjugated anti-Ly6AE MoAb (Sca-l), and biotinylated lineage marker MoAbs (Lin; B220, Mac-l, Gr-l, CD4, CD8, and TERI 19). The cells were then analyzed and sorted on a FACSta?'"' (Becton Dickinson Immunocytometry Systems, Mountain View, CA) according to the published procedure.Ix Preparation of degenerate oligonucleotide primers. Two sets of degenerate oligonucleotide primers corresponding to the consensus sequences of kinase domains (sense primer, subdomain VI; antisense primer, subdomain IX) were synthesized. One set was directed to the sequence IHRDL (FTKI) and DVWSFG (F'TKII), as described by Wilks," and the other was directed to the sequence HRDLA TGA Clone 1 : 4720bp Clone 2-6: -1 8 1 5 bp ~""""""""""""""""" 
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Fig 3 A.
STK RTK GENE IN HEMATOPOIETIC STEM CELLS
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,__"""_"~"~."". (TKI), HRDLAAR (TKII), and DVWSYFG (TKIII). TKI-I11 primers were designed to be more degenerate than PTKI and 11. Flanking sequences for Sal I and EcoRI sites were added to the TKI-I11 primers for subsequent subcloning. The sequences are as fol- 
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TAGTCGACA(C/T)(A/C)G(A/G)GA(C/T)(C/T)T(A/C/G)-GC-3'; TKII, 5'-TTGTCGACAC(A/C)G(A/G)GA(C/T)(C/T)T(C/
Reverse transcriptase-PCR (RT-PCR) amplification of PTK-refated sequences.
Total RNA was obtained from 5,000 Lin-ckit+Sca-l+ murine hematopoietic stem cells by small-scaled acid guanidinium thiocyanate-phenol-chloroform (AGPC) extraction." The first-strand cDNA was synthesized from all of the total RNA using avian myeloblastosis virus reverse transcriptase (Life Sciences Inc, St Petersburg, FL). All of the cDNA was used as the template for amplification. The cycling parameters were 1 minute at 94°C 2 minutes at 37"C, and 3 minutes at 72°C. In the first experiment, cDNA was primed with ologo(dT) and the amplification proceeded for 40 cycles with 1 pg of PTKI and PTKII primers. The second experiment included a two-step amplification. The cDNA was primed with TKIII primer, and the first amplification was performed for 40 cycles with 1 pg of TKI and TKIII primers. After the PCR products were purified using a Suprec-01 column (Takara Shuzo, Kyoto, Japan), an additional 20 cycles of amplification were performed with I pg of TKII and TKIII primers. The amplified cDNA of around 210 bp was subcloned into the pCRlOOO vector (Invitrogene, San Diego, CA) according to the manufacturer's instructions (first experiment), or, after digestion with Sal I and EcoRI, subcloned into the Bluescript vector (Stratagene, La Jolla, CA; second experiment). Inserts of 50 randomly selected clones were sequenced by dideoxynucleotide chain termination, using an AutoRead sequence kit and the Automated Laser Fluorescent ALF DNA Sequencer (Pharmacia, Uppsala, .Sweden).
Screening of cDMA libraries. A MEL cell cDNA library (in XgtlO) was screened with the ["P]-labeled PCR-amplified stk-5 insert. About 5 X I O 5 recombinants were screened under the following conditions. Hybridization was performed at 65°C in 5x SSPE, 5X Denhardt's solution, 0.5% sodium dodecyl sulfate (SDS), and 200 Fg/mL denatured salmon sperm DNA for 16 hours. Membranes were washed to a final stringency of 0.1 X SSPE and 0.1 % SDS at 65°C. The cDNA inserts of positive clones were subcloned into the Bluescript vector and sequenced as described above.
Anchored PCR. Anchored PCR to extend the truncated form of cDNA into the 5' direction was performed as describedz3 using poly(A)+RNA from MEL cells. An antisense oligonucleotide, 5'-TCCGTC'ITCGGGAGTTAAAGATCAG-3' (Fig 3B, nucleotide  330 to 354) , was used for the first-strand cDNA synthesis and 5'-AATGGGACACCATCCTTGCCAAGTTG-3' (Fig 3B, nucleotide  171 to 196) was used for amplification. The parameters were 40 cycles of I minute at 9 4 T , 2 minutes at 5 5 T , and 3 minutes at 72°C. The PCR product was subcloned into the Bluescript vector by blunt-end ligation.
Northern blotting. Total RNA was isolated from tissues and cell lines by means of AGPC extracti~n?~ and poly(A)+RNA was se- 
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~------. lected using Oligotex-dT30 (Takara Shuzo). Two micrograms of poly(A)+RNA was loaded onto a formaldehyde gel, which was Northern blotted as described?' using a Zeta-Probe blotting membrane (Bio-Rad, Richmond, CA). Hybridization and washes proceeded according to the manufacturer's instructions. Probe A (Fig  2, nucleotides 2918 to 4631) and probe B (Fig 2, nucleotides 1 to 2917) were [c~-'~P]-labeled and hybridized to the blot.
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RT-PCR analysis of fractionated bone marrow cells. Fractionated bone marrow cells (Lin', Lin-c-KIT, Lin-c-KIP, Lin-cKIPSca-l-, and Lin-c-KZPSca-l+) were prepared and the total RNA was obtained as described above. The first-strand cDNA was synthesized using avian myeloblastosis virus reverse transcriptase (Life Science) and random hexamer oligonucleotides. The cDNA samples, representing approximately 5,000 cells, were amplified. Cycling parameters were 40 cycles of 1 minute at 94°C. 2 minutes at 5 5 T , and 3 minutes at 72°C. Lineage-negative cells without reverse transcriptase were processed in the same way as a negative control. Mouse &actin was used as a reference gene. The primer sequences were STK sense primer (nucleotides 377 to 397), 
RESULTS
PuriJication of primitive hematopoietic stem cells. Figure 1 shows a three-color analysis of bone marrow cells by c-KIT, Sca-l, and a mixture of lineage markers (B220, Mac-1, Gr-l, CD4, CD8, and TER119). In the lineage markernegative (Lin-) population, a c-KIT and Sca-l double-positive fraction was observed that was only 0.04% to 0.08% of total nucleated bone marrow cells. Spangrude et a l Z 7 and we" have previously proven that hematopoietic stem cells exist in this fraction.
PCR amplljication of tyrosine kinase-related cDNA. To identify the RTKs critical to the proliferation of hematopoietic stem cells, we used the strategy of PCR amplification described by Wilks." In addition to the primers of Wilks (PTKI and PTKII), we prepared more degenerate oligonucleotide primers (TKI-111) corresponding to the amino acid sequences HRDLA(AR) (subdomain VI) and DVWSTYFG (subdomain E). Sense primers TKI and TKII were designed to preferentially clone RTK genes (HRDLAAR), -and not to amplify SRC-related genes (HRDLRAA). As a source of RT-PCR amplification, we sorted the highly purified Lin-cKITSca-l + hematopoietic stem cells by fluorescence-activated cell sorting (FACS).
Random sequence analyses of PCR-amplified cDNA clones identified 22 distinct kinase-related genes, including 2 putative serine/threonine kinases, 12 putative non-receptor PTKs, and 8 RTKs ( Table 1 ). The profile of the identified cDNAs differed according to the primers and more degenerate primers (TKI-111: sense primer; H R D L M ) amplified a more extended family of kinase-related genes, except for the SRC-related genes. Sixteen of the 22 genes were identical to the known kinase genes: PKCP, JAK-1, JAK-2, TYK-2, -HCK, FGR, FYN, BLK, C-FES, FER, C-ABL, C-KIT, FLK-I, FLK-2, IGRIR, and ECK.
The remaining 6 genes were novel at the point of cloning (stk series). Among them, stk-l, stk-3, and stk-4 were found to be identical to the recently isolated genes, TEK, BPK,29 and RYK,30,31 respectively. stk-0 is most homologous to mouse S6 kinase 11,32 and is supposed to be a novel serine/ threonine kinase gene. stk-2 is most homologous to murine JAK-233 and is likely to be a novel member of the JAK family. stk-5 is most homologous to c -M E T~~ and v-SEA~~ and is supposed to be a novel member of the MET RTK family.
STK cDNA sequence. A MEL cell cDNA library was screened with the PCR-amplified stk-5 insert. Six positive clones were isolated (clones 1 through 6, Fig 2) . Sequence analysis showed that stk-5 was a novel RTK gene, and we named this gene STK ($em cell-derived tyrosine kinase). Clone 1 encodes a 1,378 amino acid protein (Fig 3A) . Although the ATG codon at nucleotides 257 to 259 is surrounded by a relatively poor consensus sequence for a translation initiation site,36 it is followed by a hydrophobic sequence characteristic of a typical signal sequence. In the extracellular domain, there is a stretch of basic amino acids (KRRRR) characteristic of the putative proteolytic cleavage site, as is found in the C-MET" and the recently isolated c-SEA37 and RON3' RTKs. Many cysteine residues, including a cysteine-rich domain at positions 529 to 569, and 8 potential N-linked glycosylation sites (NxS/T) were also identified. The cytoplasmic domain has a typical kinase domain. The predicted protein sequence shows high homology with c-MET, c-SEA, and RON protein34.37.38 and these molecules share many unique structural properties, namely a putative proteolytic cleavage site, similar spacing of cysteine residues in the extracellular domain, and two conserved tyrosines in the carboxyterminal tail (Fig 4) . The homology with the murine c-MET protein, chicken c-SEA protein, and human RON protein was 31.6%, 45.0%, and 73.6% in total, and 65.8%, 70.0%, and 88.6% in the kinase domain, respectively.
The other 5 clones (clones 2 through 6 ) were identical to clone I, except that they lack nucleotides 1 to 2917 and have 8 unique nucleotides in their amino terminus (Fig 3B) . We performed anchored PCR to extend this truncated cDNA into the 5' direction, and we could extend more 45 nucleotides ( Fig 3B) . There is a 85-bp-long intron between nucleotides 2917 and 2918 of clone 1 and 53 bp of unique nucleotide sequence in the truncated cDNA is derived from this intron (data not shown). The size of the composite truncated cDNA (1,856 bp) is in good agreement with that detected by Northern blotting (1.8 to 1.9 kb; Fig 5A) . The first inframe methionine (nucleotides 96 to 98) is surrounded by a consensus sequence for a translation initiation site and there is an in-frame stop codon upstream of this methionine. The coding region likely begins with this methionine and this cDNA is supposed to encode a transmembrane protein that lacks most of the extracellular domain. The expression of STK gene. Probe A (Fig 2, nucleotides  29 18 to 463 1) detected abundant expression of 1.8 to 1.9 kb mRNA and faint expression of 4.8-kb mRNA in MEL cells by Northern blotting, whereas the long clone-specific probe B (Fig 2, nucleotides 1 to 2917) detected only a 4.8-kb mRNA (Fig 5A) . A similar profile of moderate and faint mRNA expression was detected in DA-1 and L8057 cells, respectively, whereas there was no signal in MI cells and stromal cell lines (PA-6, stimulated PA-6 with phorbol 12-myristate 13-acetate [PMA] and lipopolysaccharide [LPS] , and 10T1/2). The mRNA expression was markedly downregulated when MEL cells were induced into erythroid lineage with dimethylsulfoxide (DMSO; Fig 5B) . In lymphoid cell lines ( E U , CTLL, and 70zJ3) and adult tissues (brain, thymus, heart, lung, liver, spleen, bone marrow, kidney, stomach, intestine, colon, testis, and skeletal muscle), neither probe detected any apparent mRNA expression (data not shown).
RT-PCR analysis was performed on FACS-sorted fractionated bone marrow cells (Fig 6) . The expression of mRNA was detected in all differentiation stages of hematopoietic cells, including the Lin-c-Kit+Sca-l' stem cell fraction.
Chromosomal localization. The in situ hybridization patterns are shown in PA-6 cells were treated with 5 nglmL PMA and 1 pglmL LPS for 3 days. Loading was normalized by probing with a p-actin probe. The blot was exposed for 2 days.
exclude the SRC-related kinase family, we modified the PCR primers and they functioned as we expected. Thus, the types of identified genes depend on the PCR primers, but the incidence of each PTK seems to reflect their expression in stem cells.
Most of the SRC-related kinase genes known to be involved in hematopoiesis were detected. These genes are reported to play an important role in signal transduction in the restricted cell lineages, HCP' and FGR"* in differentiated myeloid cells, FYN" in T cells, and BLK"4 and B P P 9 in B cells. The biologic significance of the coexpression of these genes in stem cells remains to be clarified.
Members of the JAK family, including a novel one, were also identified. Recently, JAK-2 was reported to associate with the erythropoietin receptor? This family may function downstream of cytokine receptors and/or receptor tyrosine kinases in stem cells. RYKIMRK is distributed broadly in hematopoietic cell^.^^^^' IGFI enhances the growth of erythroid and lymphoid precursor cells.' Although ECK was originally cloned from epithelial it was expressed in stem cells in this study and also in megakaryocytic lineage in our experiments!' However, the question arose as to whether these kinases are functional or dispensable in stem cells. Some unknown ligands of these RTKs should m o w the proliferation and differentiation of stem cells.
In this study, the full sequence of the novel clone, STK, was characterized. Sequence analysis showed that STK was a novel RTK gene and composes a subfamily of RTK with c-MET, c-SEA, and the recently identified RON gene. Among these members, STK is most homologous to the human RON (73.6% at the amino acid level). Moreover, STK was localized to the R-positive F1 band of chromosome 9. The RON gene has been localized to chromosome 3~2 1 . '~ The conserved linkage homology between human chromosome 3p21 and mouse chromosome 9 has been reported."' These data suggest that murine STK is the putative murine homologue of the human RON gene.
In contrast to the relatively broad distribution of murine . In MET and c-SEA, the expression of the longest transcript was dominant and only this cDNA sequence has been clarified. On the other hand, the shorter transcript was dominant in human RON and murine STK and the corresponding cDNA was identified in this study. The shorter transcript encoded a putative transmembrane protein that lacks most of the extracellular domain. transcript is translated to a mature cell surface protein that binds to the putative ligand remains to be resolved.
The structural similarity of STK protein with c-MET evokes the possibility that the putative STK ligand may be of the HGF family. As in the HGFfc-MET system," a putative STK ligand may be functional in hematopoietic progenitor cells. HGF-like proteid"." is a candidate for the ligand for STK. It is interesting that STKIRON and HGF-like protein are mapped to the same region on both of human and mouse chromosome."8~4050 However, the diversity of the MET RTK family suggests that there are more unidentified members of the HGF family.
In this study, the expression of various tyrosine kinases, including murine STK, was detected in murine hematopoietic stem cells. Characterization of these kinases will be helpful to elucidate the molecular mechanism of the growth regulation of hematopoietic stem cells.
